This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Veeva Systems Introduces Regulatory Compliant Email Solution For Global Life Sciences Companies

PLEASANTON, California, February 14, 2013 /PRNewswire/ --

Veeva Systems' new Approved Email solution is set to radically increase the productivity of life sciences sales teams by enabling users to email approved content to customers directly from iRep and Veeva CRM. Veeva CRM Approved Email represents a technology and business breakthrough in the industry as the first end-to-end solution to enable regulatory compliant email communication between sales reps and healthcare practitioners. The pharmaceutical industry can now increase the number and quality of rep-to-customer interactions, reach more low-access and no-see healthcare practitioners and deliver more relevant drug information to customers - without increasing the size of the sales force.

     (Photo: http://photos.prnewswire.com/prnh/20120425/527164 )

"The pharmaceutical industry is one of the last to equip its sales teams with non-personal promotion channels. In every other industry, reps communicate with their customers via multiple channels, especially email. However, Pharma has been limited due to the risk of non-compliance by making an unapproved claim or off-label communication. Giving companies a controlled way to distribute content electronically will transform the customer interaction," said Eric Newmark, program director for IDC Health Insights.

Veeva's email solution comes at just the right time for the life sciences industry since the ability to traverse multiple communication channels is now required. According to an AccessMonitorâ„¢ report, the number of physicians willing to see reps has declined 20% in the last five years, making alternate forms of communication like email a must. "Even among rep-accessible physicians, 94% of primary care providers do not see even their best reps more than twice a month," the report stated.

The key to Approved Email is the focus on both regulatory compliance and user experience. The solution combines Vault PromoMats, a leading solution for the management of promotional materials, with the market leading Veeva CRM and iRep solutions for managing customer relationships. Together, Approved Email ensures only the right, approved content is sent to customers every time, while storing the full history of every interaction in Veeva CRM. Built-in controls - such as physician opt in/opt out management and off-label restrictions - help to further ensure regulatory compliance. And, because Approved Email is built into Veeva CRM and iRep, it's quick and easy for users to send personalized and compliant email from any device.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,135.72 +38.82 0.21%
S&P 500 2,101.04 +2.51 0.12%
NASDAQ 4,982.8090 +15.6680 0.32%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs